According to FutureWise analysis the surgical sealants and adhesives market in 2025 is US$ 2.79 billion, and is expected to reach US$ 5.90 billion by 2033 at a CAGR of 9.81%. The growth in the medical field is driven by an increase in surgical procedures, a preference for minimally invasive techniques, and a demand for effective wound closure solutions. Innovations in bio-based and synthetic adhesives are enhancing hemostasis, tissue bonding, and post-operative recovery across various surgical specialties.
Surgical sealants play a crucial role in medical procedures by preventing fluid leakage during surgical incisions. They are predominantly utilized in vascular reconstruction to achieve mechanical hemostasis. Additionally, surgical sealants are employed in various applications, including aortic root replacements, suture line closures, anastomoses, and to prevent arterial venous bleeding.
Most commercially available surgical sealants are characterized by their flexibility, biocompatibility, and biodegradability. They can be classified into three main categories: synthetic, natural, or a combination of both. Natural sealants typically comprise polypeptides/proteins and polysaccharides, while synthetic options include polyurethane and polyethylene glycol polymer adhesives.
The growth of the surgical sealant market is largely driven by the rising incidence of invasive surgeries. Traditionally, sutures, wires, and staples have been the go-to methods for wound sealing, yet these can present significant risks such as tissue damage, infection, and delayed tissue repair. With rapid technological advancements, surgical sealants are increasingly replacing these traditional methods, contributing to the market's expansion. Recent innovations have led to the development of biocompatible sealants, which help reduce complications associated with invasive procedures and allow normal tissue movement without disrupting organ function.
Among the various types of surgical sealants, synthetic adhesives stand out due to their high mechanical and adhesive strength, making them particularly appealing over natural sealants. This segment is anticipated to experience substantial growth during the forecast period, further boosting the market for surgical sealants.
FutureWise Market Research has published a report that provides an insightful analysis of Surgical Sealants and Adhesives Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=9&type=requestsample
Surgical Sealants and Adhesives Market Segmentation:
By Product
• Natural or Biological Sealants and Adhesives
o Fibrin Sealant
o Gelatin-based Adhesives
o Collagen-based Adhesive
• Synthetic and Semi-synthetic Adhesives
o Cyanoacrylates
o Polymeric Hydrogels
o Polyethylene Glycol Polymer
o Other Synthetic and Semi-synthetic Adhesives

By Indication
• Tissue Sealing
• Surgical Hemostasis
• Tissue Engineering

By Application
• Cardiovascular Surgery
• General Surgery
• CNS Surgery
• Orthopedic Surgery
• Cosmetic Surgery
• Urological Surgery
• Pulmonary Surgery
• Ophthalmic Surgery
• Other Applications

By End User
• Hospitals
• Clinics
• Other End Users

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Surgical Sealants and Adhesives Market:
• Johnson & Johnson (Ethicon, Inc.)
• Baxter International, Inc.
• Becton, Dickinson and Company
• CryoLife, Inc.
• Cardinal Health, Inc.
• B. Braun Melsungen A.G.
• Integra Lifesciences Holdings Corporation
• Medline Industries, Inc.
• Adhezion Biomedical, LLC.
• Tricol Biomedical, Inc.
• Vivostat A/S
• Advanced Medical Solutions Group plc.
• Stryker Corporation
• CSL Limited
• Ocular Therapeutix, Inc.
• MicroVal
• GEM Srl.
• Hemostasis, LLC.
• Péters Surgical
• Tissuemed Ltd.

Recent developments by key players in Surgical Sealants and Adhesives Market:

Johnson & Johnson (Ethicon, Inc.)
• Aug 2024: Collaborated with a regenerative medicine institute to jointly develop bioactive sealants, resulting in a 29% enhancement in wound closure rates during preclinical trials.
• Nov 2023: Introduced Ethizia, a hemostatic sealing patch aimed at accelerating bleeding control in surgical procedures—fully absorbing within 28 days to minimize tissue reaction.

Integra Lifesciences
In September 2023, the acquisition of Veritera was finalized, incorporating its collagen-based VERITASEAL tissue sealant—enhancing Integra’s range of advanced biological adhesive technology.


Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=9&license=multi


**Objectives of this Study: **
1. To provide a comprehensive analysis of the Surgical Sealants and Adhesives Market By Product, By Indication, By Application, By End User and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com